FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
30 Jan 2023
New Ways of Working in a new era: EORTC new hybrid work model based on collaboration and flexibility
19 Jan 2022
RECIST disease assessment is effective for targeted treatment as well as classical chemotherapy
5 Apr 2019
EORTC trial to improve treatment for older patients with acute myeloid leukemia enrolls first patients
16 Dec 2014
EORTC’s Anastassia Negrouk speaks out on the EU Data Protection Regulation
15 Dec 2014
Male and female breast cancers are not identical
12 Dec 2014
New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers
9 Dec 2014
EORTC to study cancer diagnostic/treatment approaches in nursing homes with the support of Armonea
3 Dec 2014
